Literature DB >> 3358683

Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy.

R L Rossi1, B Cady, M L Silverman, M S Wool, S G ReMine, M B Hodge, F A Salzman.   

Abstract

A series of 97 consecutive patients with well-differentiated thyroid carcinoma treated between 1941 and 1970 presented with distant metastatic disease or extensive nonresectable local neck disease or had residual carcinoma after thyroid resection. Men 40 years of age or younger and women 50 years of age or younger were considered at low risk for dying of disease; older patients were considered at high risk for dying of disease. Of 17 patients with distant metastatic carcinoma, 40% of younger patients in the low-risk group and 92% of older patients in the high-risk group died. Of 80 patients with unresectable or residual local neck cancer, only 13% of younger patients but 71% of older patients died. Survival related better to risk group classification as defined by age and sex than to any details of disease presentation or management. Treatment was far more successful in patients in the low-risk group.

Entities:  

Mesh:

Year:  1988        PMID: 3358683     DOI: 10.1001/archsurg.1988.01400290051008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Surgical treatment of locally advanced thyroid cancer.

Authors:  K Sugino; Y Kure; O Ozaki; K Ito; A Matsumoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.

Authors:  Jacqueline Jonklaas; Hala Nsouli-Maktabi; Steven J Soldin
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

3.  Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Sungyoung Auh; Marvin Gershengorn; Brianna Daley; Athanasios Bikas; Kenneth Burman; Leonard Wartofsky; Mark Urken; Eliza Dewey; Robert Smallridge; Ana-Maria Chindris; Electron Kebebew
Journal:  JAMA Netw Open       Date:  2019-02-01

Review 4.  Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis.

Authors:  Ho-Ryun Won; Eonju Jeon; Jae Won Chang; Yea Eun Kang; Kunho Song; Sun Wook Kim; Dong Mee Lim; Tae Kwun Ha; Ki-Wook Chung; Hyo-Jeong Kim; Young Joo Park; Bon Seok Koo
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.